Skip to main content
. Author manuscript; available in PMC: 2009 Jul 1.
Published in final edited form as: Free Radic Biol Med. 2008 Apr 8;45(1):81–85. doi: 10.1016/j.freeradbiomed.2008.03.015

Table II.

Characteristics of control and AD patients (mean ± SD)

Demographic Variables Control Subjects AD Subjects
Number of subjects 5 5
Gender (male/female) 3/2 3/2
Age at death (yrs) 87.0 ± 3.94 85.8 ± 6.02
Postmortem interval (h) 2.9 ± 0.70 3.4 ± 1.4
MMSE; number of months prior to death test taken 28 ± 0.8; 6.6 ± 1.4 15.7 ± 2.6; 19.7 ± 1.0
APOE genotype, if known (N) 3/3 (3) 3/4 (2) ND

AD, Alzheimer’s Disease; MMSE, Mini-Mental State Examination; APOE, apolipoprotein E; ND, not determined; N, number of individuals; SD, standard deviation; COPD, chronic obstructive pulmonary disease [adapted from [11].